Table 1

Patterns of p14ARF promoter hypermethylation in human cancer (n = 559)

Tumor typeSamples with aberrant methylation
Colorectal28% (37/132a)
Gastric26% (31/118)
Esophageal22% (8/37)
Endometrial16% (4/25)
Renal13% (5/38)
Gliomas9% (2/22)
Ovarian5% (1/20)
Lung5% (1/20)
Leukemia5% (1/20)
Bladder5% (1/20)
Head and neck4% (1/25)
Breast0% (0/20)
Pancreas0% (0/20)
Liver0% (0/20)
Lymphomas0% (0/22)
  • a 110 of these samples were previously described in Ref. 14 .